BEAT · XBRL financial data

HeartBeam financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (BEAT's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Research and development	255	5,677	6,798	11,051	13,450
General and administrative	2,030	7,354	8,516	8,836	7,689
Total operating expenses	2,285	13,031	15,314	19,887	21,139
Operating income (loss)	(2,285)	(13,031)	(15,314)	(19,887)	(21,139)
Interest expense	2,165	—	—	—	—
Other income (expense)	22	3	0	(7)	2
Income tax expense (benefit)	0	0	0	0	0
Net income (loss)	(4,428)	(12,962)	(14,639)	(19,448)	(21,015)
Earnings per share, basic USD per share	(1.03)	(1.59)	(0.72)	(0.73)	(0.62)
Earnings per share, diluted USD per share	(1.03)	(1.59)	(0.72)	(0.73)	(0.62)
Weighted average shares, basic thousands of shares	4,285	8,169	20,333	26,645	33,710
Weighted average shares, diluted thousands of shares	4,285	8,169	20,333	26,645	33,710

Fiscal years (BEAT's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	13,192	3,594	16,189	2,377	4,380
Inventory	—	—	—	0	103
Prepaid and other current assets	806	445	636	393	202
Total current assets	—	4,039	16,825	2,770	4,685
Property and equipment, net	—	0	256	450	1,102
Total assets	13,998	4,039	17,131	3,276	5,843
Accounts payable	—	—	556	531	1,053
Accrued liabilities	—	—	638	1,091	2,187
Total current liabilities	—	—	1,194	1,622	3,240
Total liabilities	588	1,665	1,194	1,622	3,240
Accumulated deficit	(9,224)	(22,186)	(36,825)	(56,273)	(77,288)
Total stockholders' equity	13,410	2,374	15,937	1,654	2,603
Total liabilities and equity	13,998	4,039	17,131	3,276	5,843
Common shares outstanding (cover page) thousands of shares	7,959	8,227	26,329	33,725	41,088

Fiscal years (BEAT's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(4,428)	(12,962)	(14,639)	(19,448)	(21,015)
Stock-based compensation	192	1,120	3,208	4,299	5,147
Net cash from operating activities	(3,230)	(9,948)	(12,093)	(14,471)	(13,988)
Purchases of property and equipment	—	0	256	201	600
Net cash from investing activities	—	0	(256)	(201)	(600)
Proceeds from issuing common stock	14,713	348	24,764	730	—
Proceeds from issuing equity	14,713	—	—	—	—
Net cash from financing activities	16,398	350	24,994	866	16,591
Net change in cash	13,168	(9,598)	12,645	(13,806)	2,003

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
HeartBeam	8,722	not reported	(3,342)*	56.3M	2.6 quarters	Q2 FY26 10-QJun 30, 2026
Modular Medical	3,920	not reported	(5,972)	8.2M	0.7 quarters	Q1 FY27 10-QJun 30, 2026
Vicarious Surgical	1,407	not reported	(6,325)	not reported	0.6 quarters	Q1 FY26 10-QMar 31, 2026
Milestone Scientific	2,067	not reported	(585)*	88.7M	3.5 quarters	Q2 FY26 10-QJun 30, 2026
QT Imaging Holdings	10,924	7,435	(4,837)*	14.6M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Nuo Therapeutics	449	not reported	(236)*	48.4M	1.9 quarters	Q2 FY26 10-QJun 30, 2026
Alpha Pro Tech	18,901	not reported	2,213*	10.2M	—	Q2 FY26 10-QJun 30, 2026
Cerenome	2,366	411	(7,132)*	7.6M	1.2 quarters	Q2 FY26 10-QJun 30, 2026
Hyperfine	43,458	3,904	(7,268)*	not reported	6.0 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.